The Biden administration announced support for waiving intellectual property protections (i.e. patents) for coronavirus vaccines, citing the ongoing global health crisis. The waiver (which would require WTO support) would potentially allow the vaccines to be produced and distributed more broadly around the world.
The New Paper
This story is from the May 6, 2021 edition of The New Paper. To receive TNP daily subscribe below.
By subscribing, you agree to our Terms of Service & Privacy Policy.
